BioUtah News

Halia Therapeutics Published in Journey of Drug Targeting

Halia Therapeutics Published in Journey of Drug Targeting
CancerVax Achieves Major Milestones and Files Foundational Patent Application

The Company filed a substantial non-provisional PCT patent application seeking worldwide protection for its novel cancer treatment platform
Epic Ventures Gains $200M Fresh Capital

Epic Ventures Gains $200M Fresh Capital
Canyon Labs Open House

Canyon Labs Opens Expanded Facility
CivicaScript® launches low-cost treatment to improve walking for people with multiple sclerosis

CivicaScript®, LLC, a nonprofit company dedicated to bringing low-cost generic medicines to U.S. patients, today announced the availability…
HUNTSMAN MENTAL HEALTH INSTITUTE CELEBRATES 10 YEARS OF BEHAVIORAL HEALTH INTEGRATION PROGRAM

The groundbreaking care model expanded from 5 to 15+ clinic locations to achieve 15% patient penetration rate, exceeding…
SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition

SALT LAKE CITY, Utah, Aug. 15, 2025 (GLOBE NEWSWIRE) — SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the…
First Patient Enrolled in Merit Medical’s WRAPSODY (WRAP) North America Registry

The WRAP North America registry is a prospective, multicenter study designed to collect real-world safety and effectiveness data…
Shedding Light On Cardiac Repair: How Red-Light Preconditioning Improves Cell Therapy

Following a heart attack, fibrosis is the primary obstacle to recovery. Healthy heart muscle is replaced with non-functional…
Owlet® Achieves TGA Certification for Dream Sock™, Paving the Way for Launch in Australia and New Zealand

Certification underscores Owlet’s commitment to bringing medically-certified infant monitoring technology to every family across the globe. LEHI, Utah–(BUSINESS…
bioMérieux receives U.S. FDA 510(k) clearance and CLIA-waiver for Anterior Nasal Swab specimens, an additional sample type for use with the BIOFIRE® SPOTFIRE® R/ST Panel Mini

Marcy-l’Étoile (France), August 18, 2025 – bioMérieux, a world leader in the field of in vitro diagnostics, today…
Nusano Cuts Ribbon on State-of-the-Art Radioisotope Production Facility

WEST VALLEY CITY, Utah – Aug. 21, 2025 – Nusano, a physics company transforming the production of radioisotopes,…

Call to Action

Experience Seamless Style and Speed

Explore More

Halia Therapeutics Published in Journey of Drug Targeting

CancerVax Achieves Major Milestones and Files Foundational Patent Application

Epic Ventures Gains $200M Fresh Capital

Canyon Labs Open House

CivicaScript® launches low-cost treatment to improve walking for people with multiple sclerosis

HUNTSMAN MENTAL HEALTH INSTITUTE CELEBRATES 10 YEARS OF BEHAVIORAL HEALTH INTEGRATION PROGRAM

SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition

First Patient Enrolled in Merit Medical’s WRAPSODY (WRAP) North America Registry

Shedding Light On Cardiac Repair: How Red-Light Preconditioning Improves Cell Therapy

Owlet® Achieves TGA Certification for Dream Sock™, Paving the Way for Launch in Australia and New Zealand

bioMérieux receives U.S. FDA 510(k) clearance and CLIA-waiver for Anterior Nasal Swab specimens, an additional sample type for use with the BIOFIRE® SPOTFIRE® R/ST Panel Mini

Nusano Cuts Ribbon on State-of-the-Art Radioisotope Production Facility

Call to Action

Post Category

Latest Posts

Social Links

SPECIAL THANKS TO OUR LEGACY & PLATINUM ELITE MEMBERS